2025 Volume 73 Issue 9 Pages 914-918
Structural transformation changes the activity of biological reactions. Neurotransmitter aralkylamines, such as phenethylamine, tyramine, dopamine, tryptamine, serotonin, and histamine, absorb aerial CO2, and heteronuclear multiple bond connectivity (HMBC) correlations between the carbon derived from CO2 and the α-hydrogen of the several amines were confirmed in the D2O solution. The isolation of methyl carbamate from phenethylamine and CO2 in water with TMSCHN2 also supported the formation of covalently bound carbamic acid in the amine aqueous solution containing CO2. Therefore, it is suggested that CO2 produced in the body would react with neurotransmitter amines to form covalently bound carbamic acid, which might affect biological reactions.
Low molecular weight compounds, which are bioactive substances, exhibit a variety of activities depending on their structure. For instance, ingestion of methanol (CH3OH) causes blindness,1–3) while 1-carbon homologated ethanol (CH3CH2OH) causes drunkenness. Also, the catecholamine, noradrenaline, works as a neurotransmitter in the brain.4,5) However, adrenaline (N-methylated noradrenaline) does not act in the brain but plays a major role in other parts of the body, such as the heart.6) Thus, the structure of a compound has a significant impact on its physiological effects.
Amine functional groups exist ubiquitously in living organisms, such as in amino acids and the catecholamine neurotransmitters. The concentration of exhaled CO2 is about 4%, and thus CO2 is constantly being produced as a metabolite in the body.7) The reaction of an amine with CO2 in water is shown in Fig. 1.8–25) Carbamic acid A is formed by a basic amine and CO2 via neutralization, and is further neutralized by another amine to form neutralized carbamic acid B. Ammonium hydrogen carbonate C is derived from carbamic acid A and water. Reactions of neutralized carbamic acid B with water, and ammonium hydrogen carbonate C with amine, give a common ammonium carbonate D. Recent efforts in our laboratory focus on CO2 capture with amines, and we found that several aralkylamines selectively reacted with CO2 in water without hydration.26–29) Many amines in neurotransmitters, such as catecholamines, are classified as aralkylamines. We hypothesized that these neurotransmitter aralkylamines would selectively react with CO2 in the body to form covalent carbamic acids A and B. Although this structural change is reversible, it is suggested that the structural change upon covalent bond formation is accompanied by a significant change in biological activity. Herein, we report the reactivity of neurotransmitter aralkylamines 1a–f with CO2 in water and the formation of covalently bound carbamic acid.
The concentration of CO2 in air is about 400 ppm (= 0.04 vol%), and the CO2 concentration in exhaled air is about 4 vol%. Therefore, in the in vivo environment involving neurotransmitters, CO2 concentrations are estimated to be at least greater than 0.04 vol%. At the beginning of this work, we focused on the aerial CO2 absorption of neurotransmitter aralkylamines 1a–f in water. A mixture of an amine (1 mmol) in water (10 mL) and a CO2 densitometer was placed in a desiccator (5.0 L), which was then sealed, and the CO2 concentration was measured over time. The results are shown in Fig. 2. Phenethylamine (1a) showed a drop in CO2 concentration from 409 to 0 ppm after 2 h. CO2 absorption of 1a in a larger sealed box has previously been reported.26) When tyramine (1b) was used, the CO2 concentration was reduced to 99 ppm after 2.5 h. In the case of dopamine (1c), which has a hydroxy group at the 3-position, the CO2 concentration decreased to 218 ppm at 2.5 h. The secondary amine adrenaline (1d) did not cause a drop in CO2 concentration. Tryptamine (1e), which has an indole skeleton, absorbed atmospheric CO2 as well as tyramine (1b), reaching 87 ppm after 2.5 h. Serotonin (1f) with a hydroxyl group at the 5-position further reduced the CO2 concentration, reaching 23 ppm after 2.5 h. Histamine (1g), which contains an imidazole skeleton, also efficiently absorbed CO2, with a value of 28 ppm after 2.5 h.
Next, NMR measurements in a CO2 environment were performed to confirm the formation of a covalent bond by the reaction of CO2 with an amine. CO2 gas was added to the D2O solution of phenethylamine (1a), and 13C-NMR spectra were measured over time (Fig. 3). After 10 s, a sharp peak at 165 ppm was detected. After 40 s, the peak at 161 ppm became the primary signal instead of that at 165 ppm. If the amine reacts with CO2 to form a covalent bond, yielding a carbamic acid derivative, a heteronuclear multiple bond connectivity (HMBC) correlation between the carbon derived from CO2 and the α-hydrogen of the amine should be observed. Indeed, when HMBC measurement was performed on the sample after 10 s, a correlation was observed between the 13C-NMR peak at 165 ppm and the 1H-NMR peak at 3.1 ppm, which corresponds to the α-hydrogen of the amine. On the other hand, in the case of the sample at 40 s, no HMBC correlation of the 13C-NMR peak at 161 ppm was detected.
The change in products over time with CO2 addition was considered as follows (Fig. 4). In the initial stage of CO2 addition at low CO2 concentration, the ratio of amine to CO2 would be 1 : 0.5, forming a neutralized carbamic acid B or ammonium hydrogen carbonate D. It is known that aralkylamines selectively absorb CO2 in air without hydration. Therefore, HMBC correlation of a neutralized carbamic acid B would be observed in a D2O solution of phenethylamine (1a) 20 s after adding CO2. At high CO2 concentration, the ratio of amine to CO2 should change to 1 : 1, forming acidic carbamic acid A and ammonium hydrogen carbonate C. In the D2O solution of phenethylamine (1a) 40 s after adding CO2, ionic ammonium hydrogen carbonate C might be the main product formed due to the hydration and acidity, which would have no HMBC correlation.
Based on the result of phenethylamine (1a), the reaction of tyramine (1b) in D2O upon CO2 addition was also investigated (Fig. 5). After 20 s, an HMBC correlation between the 13C-NMR peak at 165.20 ppm and the 1H-NMR peak at 3.26 ppm was detected. In the case of dopamine (1c), an HMBC correlation between the 13C-NMR peak at 165.24 ppm and the 1H-NMR peak at 3.18 ppm was also detected at 20 s. In the examinations of adrenaline (1d), no HMBC correlation was observed. In this case, the bulky secondary amine might prevent the formation of a covalent bond between the amine and CO2.
Next, aralkylamines containing heterocycles in D2O upon CO2 addition were measured by HMBC (Fig. 6). Although tryptamine (1e) and serotonin (1f), which include an indole skeleton, did not show the HMBC correlations, possibly due to low solubility or instability under D2O, HMBC correlations of histamine (1g) were confirmed between the carbon (13C-NMR 165.23 ppm) derived from CO2 and the α-position hydrogen (1H-NMR 3.25 ppm) of the amine upon addition of CO2 after 10 s.
Finally, methylation of phenethylamine (1a) in water and CO2 was investigated.30,31) After CO2 gas was added to the aqueous phenethylamine (1a) solution for 20 s, the resulting mixture was poured into a solution of TMSCHN2 in MeOH to afford the desired methyl carbamate (2a) in 10% yield (Fig. 7). This result suggests the formation of carbamic acid in the reaction.
In summary, neurotransmitter aralkylamines bearing primary amines absorbed CO2 under low CO2 concentration conditions (air). HMBC NMR results suggested that the corresponding amine(s)/CO2 complexes formed covalent carbamic acid intermediates even in aqueous solution. The fact that methyl carbamate was obtained from methylation in a phenethylamine aqueous solution upon addition of CO2 gas also suggested covalent bond formation between the amine and CO2. These results indicate that neurotransmitter aralkylamines would react with CO2 to form covalent bond-type carbamic acid intermediates even in the body, and the resulting carbamic acid intermediates might cause other biological reactions different from the original actions. Further exploration of the interactions between neurotransmitter aralkylamines and CO2 is ongoing.
We are thankful for the support from Panasonic and the Takeda Science Foundation.
The authors declare no conflict of interest.
This article contains supplementary materials.